The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Brichard L, Stavart C, El Hayeck J, Dahlqvist C, Bodart E

[Sertraline-induced acute eosinophilic pneumonia: When a side effect becomes a clinical case].

Revue des maladies respiratoires. 2025;42(7):382-386

Brancaleone P, Descamps O, Piquet M, Detry G, Mignon M, Weynand B

[Sertraline-induced chronic eosinophilic pneumonia].

Revue des maladies respiratoires. 2021;38(2):210-214

Muftah M, Nassri R, Nassri A, Harford P

Sertraline-Induced Acute Eosinophilic Pneumonia.

Current drug safety. 2018;13(3):196-199

Thornton C, Maher TM, Hansell D, Nicholson AG, Wells AU

Pulmonary fibrosis associated with psychotropic drug therapy: a case report.

Journal of medical case reports. 2009;3:126

Haro M, Rubio M, Xifré B, Castro P

[Acute eosinophilic pneumonia associated to sertraline].

Medicina clinica. 2002;119(16):637-8

Barnés MT, Bascuñana J, García B, Alvarez-Sala JL

Acute eosinophilic pneumonia associated with antidepressant agents.

Pharmacy world & science : PWS. 1999;21(5):241-2